Ligand validation:3EYA

FAD: FLAVIN-ADENINE DINUCLEOTIDE

FAD is a Ligand Of Interest in 3EYA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EYA_FAD_B_612	92%	32%	0.089	0.981	1.21	1.5	5	15	3	0	100%	1
3EYA_FAD_H_612	90%	31%	0.093	0.976	1.26	1.48	5	12	3	0	100%	1
3EYA_FAD_F_612	89%	33%	0.094	0.972	1.14	1.51	4	15	5	0	100%	1
3EYA_FAD_I_612	88%	36%	0.095	0.972	1.11	1.41	4	10	7	0	100%	1
3EYA_FAD_A_612	88%	32%	0.104	0.981	1.12	1.55	4	11	1	0	100%	1
3EYA_FAD_J_612	88%	34%	0.096	0.972	1.17	1.44	4	10	5	0	100%	1
3EYA_FAD_L_612	87%	30%	0.102	0.976	1.11	1.66	6	13	2	0	100%	1
3EYA_FAD_C_612	86%	29%	0.102	0.972	1.23	1.58	6	14	1	0	100%	1
3EYA_FAD_K_612	86%	36%	0.102	0.971	0.89	1.62	2	17	3	0	100%	1
3EYA_FAD_E_612	86%	37%	0.099	0.967	1.03	1.45	4	11	6	0	100%	1
3EYA_FAD_D_612	84%	30%	0.111	0.973	1.26	1.54	7	15	3	0	100%	1
3EYA_FAD_G_612	78%	33%	0.113	0.956	1.08	1.57	4	14	5	0	100%	1
3EY9_FAD_A_612	86%	38%	0.116	0.986	1.08	1.35	2	11	3	0	100%	1
2R4J_FAD_B_600	100%	13%	0.024	0.995	2	1.99	18	19	0	0	100%	1
3IC9_FAD_B_490	100%	32%	0.025	0.996	1.23	1.45	7	8	0	0	100%	1
4OMF_FAD_B_405	100%	14%	0.015	0.998	2.27	1.57	9	13	0	0	100%	1
9GXB_FAD_A_301	100%	75%	0.022	0.995	0.45	0.53	-	1	1	0	100%	1
9H8Q_FAD_H_602	100%	57%	0.023	0.995	0.69	0.95	-	4	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.